首页> 外文期刊>Biomedicine & pharmacotherapy =: Biomedecine & pharmacotherapie >MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression
【24h】

MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression

机译:MiR-661通过抑制INPP5J表达,有助于人类卵巢癌细胞的细胞增殖

获取原文
获取原文并翻译 | 示例
           

摘要

Accumulating evidence has emerged important roles for microRNAs (miRNAs) participating in oncogenesis and growth of various cancers. We hypothesized that miR-661 played an important role in cell growth of ovarian cancer. Here, we found miR-661 was upregulated in human ovarian cancer cell lines and clinical tumor tissues. Our results revealed that miR-661 directly targeted INPP5J, thereby acting as tumor promoter in ovarian cancer cells by blocking cell proliferation. Importantly, we identified miR-661 as a positive regulator of INPP5J-induced AKT pathway. Taken together, our study sheds light onto the role of miR-661 as tumor promoter by targeting the INPP5J gene, and then promoting cell proliferation of ovarian cancer. (C) 2015 Elsevier Masson SAS. All rights reserved.
机译:积累证据已经出现了参与血管生成和各种癌症生长的MicroRNAS(miRNA)的重要作用。 我们假设MiR-661在卵巢癌细胞生长中发挥了重要作用。 在这里,我们发现MiR-661在人类卵巢癌细胞系和临床肿瘤组织中上调。 我们的结果表明,MIR-661直接靶向INPP5J,从而通过阻断细胞增殖作为卵巢癌细胞中的肿瘤启动子。 重要的是,我们将MIR-661鉴定为INPP5J诱导的AKT途径的正调节因子。 通过靶向INPP5J基因,我们的研究揭示了MiR-661作为肿瘤启动子的角色,然后促进卵巢癌细胞增殖。 (c)2015年Elsevier Masson SAS。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号